FDA Approval for Merck Vaccine Targeting Pneumonia-Causing Bacteria
Monday, 17 June 2024, 21:21
Merck's Vaccine Approval by FDA
Merck's new vaccine has been approved by the FDA to counter 21 strains of bacteria causing severe pneumococcal disease.
Protection from Pneumonia and Infections
The vaccine targets a lung infection known as pneumonia, safeguarding adults from serious health risks.
- Preventing Severe Infections: Merck's vaccine acts against multiple strains of bacteria to prevent severe diseases.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.